Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ CM
  • Sector: Technology
  • Industry: Software
  • Sub-Industry: Application Software

Simulations Plus Inc

+ Add to Watchlist

SLP:US

6.3600 USD 0.1300 2.00%

As of 20:10:00 ET on 01/30/2015.

Snapshot for Simulations Plus Inc (SLP)

Open: 6.5000 Day's Range: 6.1800 - 6.5000 Volume: 10,124
Previous Close: 6.4900 52wk Range: 5.2000 - 7.1500 1-Yr Rtn: +16.19%

Stock Chart for SLP

No chart data available.
  • SLP:US 6.3600
  • 1D
  • 1M
  • 1Y
6.4900
Interactive SLP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SLP

Current P/E Ratio (ttm) 36.6571
Estimated P/E(08/2015) 28.9091
Relative P/E vs. SPX 2.0866
Earnings Per Share (USD) (ttm) 0.1735
Est. EPS (USD) (08/2015) 0.2200
Est. PEG Ratio 1.4455
Market Cap (M USD) 107.18
Shares Outstanding (M) 16.85
30 Day Average Volume 12,967
Price/Book (mrq) 5.8006
Price/Sale (ttm) 8.0780
Dividend Indicated Gross Yield 3.14%
Cash Dividend (USD) 0.0500
Dividend Ex-Date 01/22/2015
5 Year Dividend Growth -
Next Earnings Announcement 04/09/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SLP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SLP

Simulations Plus, Inc. develops drug discovery and development simulation software, which is licensed to and used in the conduct of drug research for pharmaceutical companies worldwide. The Company's other businesses are based on its proprietary software technologies and provide support for the emerging pharmaceutical enterprise.

Walter S Woltosz "Walt"Chairman/CEO/Co-FounderThaddeus H Grasela "Ted"President
John R KneiselChief Financial OfficerJohn A DibellaVP:Marketing & Sales
More Company Profile & Key Executives for SLP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil